Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
20 May, 2026, 02.53 PM IST
Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
20 Mar, 2026, 03.52 PM IST
Novartis signs up to $5.2 billion heart drugs licensing deal with China's ArgoNovartis has entered into a licensing and options agreement with Argo Biopharmaceutical, valued at up to $5.2 billion. The deal encompasses...
03 Sep, 2025, 05.26 PM IST
Roche says controlling family won't have to make offer to other shareholdersThe pool of family shareholders, who previously owned 45.01% of the voting rights in Roche, were given the exemption by the Swiss takeover ...
05 Nov, 2021, 01.43 PM IST
Novartis agrees to make ingredients Roche's Actemra for COVID-19 patientsThe arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...
15 Apr, 2021, 11.55 AM IST
Novartis to cut 2,200 jobs in Switzerland to boost profitabilityNovartis will cut about 2,200 jobs in Switzerland over the next four years as it consolidates production and shifts positions elsewhere to ...
25 Sep, 2018, 12.48 PM IST
Rs 2,000 crore Novartis deal to help Sun Pharma rise in JapanThe discussions between Sun Pharma and Novartis, according to people privy to the matter, pertain to hiving off a handful of older products.
14 Nov, 2015, 07.30 AM IST
Novartis buys another 2.5% in Israel's Gamida CellNovartis will not have rights or options to Gamida Cell products or technology under the terms of the agreement.
11 Oct, 2015, 03.16 PM IST
Cipla asks government to revoke five patents held by NovartisCipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug O...
30 Oct, 2014, 11.35 AM IST
Novartis India vice-chairman & managing director, Ranjit Shahani says company now focuses on new products, business growthNovartis India has over the past year launched three successful patented drugs and over 12 generic drugs that have helped it expand its pre...
19 Jun, 2014, 05.49 AM IST
Novartis, Panacea call off their vaccine joint ventureSwiss drugmaker Novartis' subsidiary Chiron has snapped the eight-year-old joint venture formed with Delhi-based Panacea Biotec.
28 Aug, 2013, 04.37 AM IST
Sun Pharma takes Novartis to US Court, seeks permission to market Glivec in USUntil and unless Sun obtains a court decision of non-infringement and/or invalidity on the ’051 patent, it faces the risk of patent infring...
13 Jun, 2013, 04.10 AM IST
Novartis wants Indian patent system to improve, compares with ChinaWe will continue with our investments in India, though cautiously. We hope that the ecosystem for intellectual property improves, Ranjit Sh...
01 Apr, 2013, 03.40 PM IST
Novartis’ outgoing chief to forgo $78-million exit paySwiss shareholder rights groups had said the agreement should be scrapped after the size of the payoff was reported by a Swiss blog.
20 Feb, 2013, 05.55 AM IST
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 m
Hyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
24 Jan, 2011, 06.30 AM IST
- Novartis gets US approval for meningitis vaccine
Novartis AG said that its meningitis vaccine Menveo has been approved for use in teenagers and adults by the US Food and Drug Administratio...
22 Feb, 2010, 05.25 PM IST
- Swiss drugmaker Novartis to cut 2,500 jobs
Swiss drugmaker Novartis said plans to cut 2,500 jobs in a restructuring programme aimed at generating yearly cost savings of 1.6 billion d...
13 Dec, 2007, 01.10 PM IST